Filing Details
- Accession Number:
- 0000899243-18-014568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-31 17:22:31
- Reporting Period:
- 2018-05-29
- Accepted Time:
- 2018-05-31 17:22:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1461993 | Melinta Therapeutics Inc. W | MLNT | Pharmaceutical Preparations (2834) | 454440364 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1722374 | Paul Estrem | C/O Melinta Therapeutics, Inc. 300 George Street, Suite 301 New Haven CT 06511 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-29 | 10,000 | $5.00 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These shares were purchased from the underwriters pursuant to an underwritten public offering by the Issuer. The offering closed on May 29, 2018.
Billionaire Hedge Funds
